Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 90713 refers to the inactivated poliovirus vaccine (IPV), which is administered either subcutaneously or intramuscularly. Vaccines, such as IPV, are designed to provide active, long-term immunity by stimulating the recipient's immune system. Unlike immune globulins that offer short-term, passive immunity, vaccines expose the immune system to altered forms of specific viruses or bacteria. This exposure prompts the immune system to produce its own antibodies, which are crucial for defending against future infections by the same pathogen. The body retains a memory of how to produce these antibodies, ensuring a quicker and more effective response upon subsequent exposures to the antigen. It is important to note that CPT® Code 90713 specifically reports the use of the inactivated poliovirus vaccine itself, rather than any associated services or procedures. This code is essential for accurate medical coding and billing related to immunization services.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The inactivated poliovirus vaccine (IPV) is indicated for the prevention of poliomyelitis, a viral disease that can lead to paralysis and other serious complications. The vaccine is recommended for individuals, particularly children, who are at risk of exposure to the poliovirus. Vaccination is crucial in areas where poliovirus is still present or where there is a risk of outbreaks. The IPV is part of routine childhood immunization schedules and is administered to ensure long-term immunity against poliovirus infection.

  • Prevention of Poliomyelitis The primary indication for administering the IPV is to prevent poliomyelitis, a potentially debilitating viral infection.
  • Routine Immunization IPV is recommended as part of the standard immunization schedule for children to protect against poliovirus.
  • Risk of Exposure The vaccine is indicated for individuals, especially children, who may be at risk of exposure to the poliovirus in endemic areas.

2. Procedure

The administration of the inactivated poliovirus vaccine (IPV) involves specific procedural steps to ensure safety and efficacy. The following outlines the key steps in the vaccination process:

  • Step 1: Preparation Prior to administration, the healthcare provider must prepare the vaccine by checking the expiration date and ensuring that the vaccine is stored at the appropriate temperature. The vial should be visually inspected for any particulate matter or discoloration.
  • Step 2: Patient Assessment The healthcare provider should assess the patient’s medical history, including any previous allergic reactions to vaccines, current health status, and any contraindications to vaccination. This assessment is crucial to ensure the safety of the patient.
  • Step 3: Administration The IPV can be administered either subcutaneously or intramuscularly. The provider should select an appropriate injection site, typically the anterolateral thigh for infants and the deltoid muscle for older children and adults. The vaccine is injected using a sterile syringe and needle, following standard aseptic techniques.
  • Step 4: Post-Administration Care After the vaccine is administered, the healthcare provider should observe the patient for a brief period to monitor for any immediate adverse reactions. Patients should be informed about potential side effects and the importance of completing the vaccination series as per the recommended schedule.

3. Post-Procedure

Following the administration of the inactivated poliovirus vaccine (IPV), patients may experience mild side effects, such as soreness at the injection site, low-grade fever, or irritability. These reactions are typically short-lived and resolve without intervention. It is important for healthcare providers to educate patients and caregivers about these potential side effects and to encourage them to report any unusual or severe reactions. Additionally, patients should be advised to follow the recommended immunization schedule to ensure complete protection against poliovirus. Documentation of the vaccination in the patient's medical record is essential for tracking immunization status and for future healthcare needs.

Short Descr POLIOVIRUS IPV SC/IM
Medium Descr POLIOVIRUS VACCINE INACTIVATED SUBQ/IM
Long Descr Poliovirus vaccine, inactivated (IPV), for subcutaneous or intramuscular use
Status Code Excluded from Physician Fee Schedule by Regulation
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
Type of Service (TOS) 1 - Medical Care
Berenson-Eggers TOS (BETOS) O1G - Immunizations/Vaccinations
MUE 1
CCS Clinical Classification 228 - Prophylactic vaccinations and inoculations
GA Waiver of liability statement issued as required by payer policy, individual case
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
25 Significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure or other service: it may be necessary to indicate that on the day a procedure or service identified by a cpt code was performed, the patient's condition required a significant, separately identifiable e/m service above and beyond the other service provided or beyond the usual preoperative and postoperative care associated with the procedure that was performed. a significant, separately identifiable e/m service is defined or substantiated by documentation that satisfies the relevant criteria for the respective e/m service to be reported (see evaluation and management services guidelines for instructions on determining level of e/m service). the e/m service may be prompted by the symptom or condition for which the procedure and/or service was provided. as such, different diagnoses are not required for reporting of the e/m services on the same date. this circumstance may be reported by adding modifier 25 to the appropriate level of e/m service. note: this modifier is not used to report an e/m service that resulted in a decision to perform surgery. see modifier 57 for significant, separately identifiable non-e/m services, see modifier 59.
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
CC Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed)
CR Catastrophe/disaster related
GC This service has been performed in part by a resident under the direction of a teaching physician
GX Notice of liability issued, voluntary under payer policy
GZ Item or service expected to be denied as not reasonable and necessary
JZ Zero drug amount discarded/not administered to any patient
PD Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
SL State supplied vaccine
UC Medicaid level of care 12, as defined by each state
X1 Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care
Date
Action
Notes
2011-01-01 Changed Short description changed.
2008-01-01 Changed Code description changed.
2006-01-01 Changed Code description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"